-
Biotechs That Might Benefit From Ebola Research
Monday, August 11, 2014 - 3:29pm | 389Read More...A lot of news has been circulating in regards to stocks that could benefit from the recent Ebola virus outbreak. Although investors might want to proceed with caution when it comes to these news-driven biotech stocks, it never hurts to review the landscape for potential opportunities. Related...
-
4 Ebola Researching Biotech Companies For Your Portfolio
Thursday, August 7, 2014 - 9:15am | 896Read More...With the death toll from West Africa’s Ebola outbreak reaching close to 1,000, serious interest is being taken into researching compounds that could both prevent outbreak and help those infected. Until recently, Ebola was a pretty rare disease, Dr. Jim Wilson told Benzinga, and the...
-
Rodman & Renshaw Provides Color on BioCryst Pharmaceuticals
Tuesday, July 5, 2011 - 7:02am | 199Read More...Rodman & Renshaw provided color on BioCryst Pharmaceuticals (NASDAQ: BCRX), following a conversation with Dr. Robert Terkeltaub. In a research report published today, Rodman & Renshaw commented on the rise of prevalence of gout among the elderly population in the United States. In the...
